Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Avalo Therapeutics Inc. buy BTIG Research

Avalo Therapeutics Inc.
Start price
€0.041
19.12.24 / 50%
Target price
€38.45
19.12.25
Performance (%)
-
End price
-
20.12.25
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Avalo Therapeutics Inc. - - -
iShares Core DAX® 3.593% 3.931% 15.378%
iShares Nasdaq 100 5.810% 5.518% 41.455%
iShares Nikkei 225® 4.075% 8.460% 48.947%
iShares S&P 500 4.142% 4.039% 31.594%

Comments by BTIG_Research for this prediction

In the thread Avalo Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 38.452
Change
Ends at 19.12.25

Avalo Therapeutics, Inc. (NASDAQ: AVTX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $40.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat

BTIG Research 
0
Report Share
19.12.24
In the thread Trading Avalo Therapeutics Inc.
Prediction Buy
Perf. (%) -
Target price 38.452
Change
Ends at 19.12.25

Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten

BTIG Research 
0
Report Share
20.12.25

Current prediction by BTIG_Research for Avalo Therapeutics Inc.

buy
Avalo Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.041
30.09.25
€34.13
30.09.26
-
28.12.23

BTIG Research 
30.09.25 50%

Stopped prediction by BTIG_Research for Avalo Therapeutics Inc.

buy
Avalo Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.041
13.04.26
€34.22
13.04.27
-
28.12.23

BTIG Research 
13.04.26 50%
buy
Avalo Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.041
24.03.26
€34.51
24.03.27
-
28.12.23

BTIG Research 
24.03.26 50%